Tue Oct 01 03:44:43 UTC 2024: ## Enzo Biochem’s Short Interest Drops as Institutional Investors Show Interest

**New York, NY** – Enzo Biochem, Inc. (NYSE: ENZ) saw a significant decrease in short interest during September, dropping 5.0% to 478,700 shares from the previous month. This represents 1.3% of the company’s outstanding shares.

Meanwhile, institutional investors continue to show interest in the medical research company. XTX Topco Ltd increased its stake in Enzo Biochem by 94.5% in the second quarter, while Wittenberg Investment Management Inc. bought a new stake in the fourth quarter. Renaissance Technologies LLC also raised its stake by 2.6% in the second quarter. In total, institutional investors and hedge funds now own 36.90% of Enzo Biochem’s stock.

Enzo Biochem’s share price closed at $1.12 on Monday, down $0.01 from the previous day. The company’s 50-day moving average price is $1.12 and its 200-day moving average price is $1.13.

Enzo Biochem specializes in developing, manufacturing, and marketing products and tools for various research sectors. The company offers a range of products, including proteins, antibodies, peptides, and kits for life science research.

**Disclaimer:** This news article is based on information provided in the original text and does not constitute investment advice. Always consult with a financial professional before making any investment decisions.

Read More